MedTrace Logo

A Clinical Study of the T3 Short Dental Implant System

NCT04237545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-05-05

No results posted yet for this study

Summary

This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.

Conditions

  • Edentulous Jaw

Interventions

DEVICE

T3 short and restoration (prosthesis)

A qualified patient will be treated with a T3 short implant according to randomization assignment during implant placement surgery visit. The implant will then be restored with a prosthesis and followed up for yearly visits for a total of 4 years.

DEVICE

T3 standard length and restoration (prosthesis)

A qualified patient will be treated with a T3 standard length implant according to randomization assignment during implant placement surgery visit. The implant will then be restored with a prosthesis and followed up for yearly visits for a total of 4 years.

Sponsors & Collaborators

  • ZimVie

    lead INDUSTRY

Principal Investigators

  • Hai Bo Wen, PhD · ZimVie

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2026-01-01
Completion
2026-03-31
FDA Device
Yes

Countries

  • United States
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04237545 on ClinicalTrials.gov